WoS ESCI Q3CAS 4区Hybrid

Journal 2731-3441

Country: Updating•WoS SCIE Quartile: Q3•Identifier (ISSN):2731-3441(Print)

Clarivate JCR Index Advisory: Active (ESCI)

Clarivate IF (2026)Q3

↑ +3

Leading citation impact metric from Clarivate Journal Citation Reports

JCR Release Date: 2026-06-17

H-Index (Hirsch Index)

N/A

papers with at least that number of citations each

WoS: ESCIQ3

Self-Citation RateN/A

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

N/Aarticles/year

58.93% Gold OA•N/A Original Research

State Council for Professorship (HĐGSNN) Scoring

Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)

1.50pts

Latest Max Score

Estimated (Dec 26)

Scoring Basis: WoS Q3(IF: 3)

HĐGSNN Score History

By article publication year

Year	Max Score	Evaluation Details	Source
2026	1.50đ	WoS Q3(IF: 3)	🔵 Computed

Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.

Aims & Scope

Journal 2731-3441 is a leading international peer-reviewed journal publishing original research, clinical updates, and reviews indexed in Clarivate Web of Science (SCIE) with Q3 quartile ranking.

SCImago & Scopus Journal Intelligence

Not indexed in SCImago / Scopus database

This journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Biology

Minor Category (Specific Field):

4区CELL & TISSUE ENGINEERING

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

Category	Index	Rank	Quartile
CELL & TISSUE ENGINEERING	JCRESCI	21/32	Q3
MATERIALS SCIENCE, BIOMATERIALS	JCRESCI	40/58	Q3
CELL & TISSUE ENGINEERING	JCIESCI	26/32	Q4
MATERIALS SCIENCE, BIOMATERIALS	JCIESCI	45/58	Q4